Improvements of myocardial strain and work in diabetes patients with normal ejection fraction after empagliflozin treatment

ConclusionsThis study suggests that 6-month treatment with empagliflozin improved LV, RV and LA functions in diabetes patients with normal ejection fraction.

Source: Journal of Diabetes Investigation - March 27, 2024 Category: Endocrinology Authors: Xueqing Cheng, Peina Huang, Hongyun Liu, Xiaojun Bi, Yiping Gao, Ruirui Lu, Yipeng Gao, Yani Liu, Youbin Deng Tags: ORIGINAL ARTICLE Source Type: research